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Electrocardiographic (ECG) recording of the
bioelectrical activity of the heart has remained vir-
tually unchanged for more than a century. Howe-
ver, advances in knowledge led to more and more
diagnostic and prognostic information being obta-
ined from the same ECG recordings. Thus, despite
continuous progress in noninvasive diagnostic me-
thods, simple and cheap ECG technology still has
an important role in clinical practice, particularly in
the diagnosis of coronary artery disease and in the
assessment of prognosis in patients with various
types of coronary artery disease.
In coronary artery disease, prognosis is rela-
ted to the degree of left ventricular dysfunction,
severity of coronary atherosclerosis, widely consi-
dered electrical instability, and non-coronary coexi-
sting conditions. Objective assessment of the de-
gree of coronary artery involvement is the most
effective way to determine prognosis but requires
invasive methods (coronary angiography, intrava-
scular ultrasound) and/or sophisticated, expensive
and not always widely available non-invasive mo-
dalities (CT, MRI). The degree of coronary artery
involvement translates into the severity of perfu-
sion defects and thus the utility of methods that
allow assessment of these parameters (SPECT,
PET). Significant perfusion abnormalities result in
myocardial ischemia that affects ST segment in the
ECG tracing. In this regard, we mostly rely on the
ST segment evaluation during stress testing (exer-
cise test or pharmacological stress with dipyrida-
mole, adenosine, and dobutamine). The prognostic
value of this assessment depends on the degree in
which ST segment changes reflect objective phe-
nomena determining prognosis. It is known that ST
segment depression and its slope depend on quali-
tative and quantitative characteristics of action
potentials and their spatial and temporary interre-
lation during both repolarization and depolarization
phases [1]. Abnormal ECG findings may result from
ischemia (with the latter not necessarily dependent
on coronary artery disease), but they may also re-
flect other factors [1, 2], thus leading to false posi-
tive results, particularly in women and patients with
hypertension [2–6]. To reduce the rate of false po-
sitive results, diagnostic criteria of “ischemic ST
depression” were limited to strictly defined quali-
tative findings (horizontal or down-sloping ST seg-
ment depression) and quantitative parameters (at
least 1 mm ST depression at 80 ms after the J po-
int) [1]. This in turn resulted in an increased rate
of false negative results. Thus, up-sloping ST seg-
ment depression of at least 1.5 mm is also conside-
red “ischemic ST depression” by some authors. One
may approach this trade-off between sensitivity and
specificity in different ways, but we can never re-
ach 100% sensitivity and specificity at the same
time. Such a trade-off inevitably leads to the detec-
tion of “ischemic ST changes” in patients without
coronary artery disease. The prognostic value of
such ECG changes is small.
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With these caveats in mind, we avoid perfor-
ming ECG stress testing in patients with a high li-
kelihood of a false positive or false negative result.
In these circumstances, we use perfusion imaging
with radionuclide stress testing that in most cases
allows, by extrapolation of gathered information,
evaluation of the severity of coronary artery invo-
lvement which is an objective prognostic parame-
ter. During these studies, ECG is also usually re-
corded. Does it have a prognostic value in such si-
tuation? Already in the 1990s it was accepted that
regardless of the ST segment changes, perfusion
abnormalities detected by SPECT indicate worse
prognosis, and their absence is associated with mi-
nimal mortality risk of < 1% per year [7–11]. Thus,
SPECT imaging was considered to have superior
value compared to ECG [12, 13]. However, in 2003
Abbott et al. [14] Klodas and et al. [15] published
reports that questioned this belief. They showed
a significant risk of a cardiac event (with a yearly
risk of death or myocardial infarction of 5–10%) in
patients with no perfusion abnormalities in SPECT
but with “ischemic ST depression” during dipyri-
damole or adenosine stress. These reports were
first to suggest a prognostic value of “ischemic ST
changes” with negative SPECT findings. Authors
suggested that such a situation may occur in pa-
tients with multivessel coronary artery disease re-
sultung in true positive ECG findings and false ne-
gative perfusion imaging with SPECT. These false
negative results (undetected but present perfusion
abnormalities) may by explained with the occurren-
ce of so-called “balanced ischemia” or “perfectly ba-
lanced” decrease in perfusion of the coronary arte-
ry tree due to a “perfectly balanced” symmetric
distribution of stenotic coronary artery lesions
[10, 11, 16–19]. In response to these reports, in this
issue of the “Cardiology Journal” Hage et al. [20]
present a study conducted in a group of 73 patients
with ischemic ST depression but without perfusion
abnormalities detected by SPECT during adenosi-
ne stress. During the mean follow-up of 5 years,
cardiac mortality in these patients was less than
1.3%. This is another long-term follow-up study, but
the first one performed in such a large group of
patients that confirms a superior prognostic role of
SPECT over ECG: with normal (true negative)
SPECT findings, the presence of concomitant ische-
mic (false positive) ST changes in ECG does not
have an adverse effect on prognosis. Thus, ST chan-
ges that were found in this study group but were
not associated with perfusion abnormalities
in SPECT should be considered not related to my-
ocardial ischemia. It should be stressed that this
conclusion might apply only to this particular study
group as available data suggest that it was a popu-
lation with a low pretest likelihood of coronary ar-
tery disease but with a significant likelihood of fal-
se positive ST segment changes (81% women,
74% patients with hypertension). Overall, these re-
ports suggest that the same findings of “ischemic
ST depression” might have varying prognostic va-
lue in patients with a negative result of stress
SPECT imaging.
In 2005, Chow et al. [21] published results of
a 2-year follow-up of patients with negative PET
imaging with dipyridamole stress, demonstrating
a very good prognosis in this group (no cardiac de-
aths, yearly myocardial infarction risk of 0.6%). The
presence of “ischemic ST changes” had no effect
on prognosis. Thus, a (truly) negative result of PET
clarified the true value of “ischemic ST changes”
which in such a case should be considered a false
positive finding. This might be explained by the fact
that the study group included 83% women and 61%
patients with hypertension. Of interest, the pretest
likelihood of coronary artery disease in this group
was similar to that in populations studied by Abbott
et al. [14] and Klodas et al. [15] while prognosis in
patients with no perfusion abnormalities in SPECT
or PET but with “ischemic ST changes” was dissi-
milar. Also, the interpretation of these “ischemic
ST changes” was different. Contrary to what some
might think, the results reported by Chow et al. [21]
do not contradict findings of Abbott et al. [14] and
Klodas et al. [15], as PET might detect perfusion
abnormalities missed by SPECT [22], thus reducing
the number of false negative SPECT results asso-
ciated with true positive ECG findings. With PET,
more true positive results are obtained that indicate
actual perfusion abnormalities accompanied by true
“ischemic ST depression” seen in ECG. In result,
negative PET finding are usually true negatives, and
any accompanying “ischemic ST changes” are false
positives that have no significant prognostic value.
One might suspect that verification of findings re-
ported by Abbott et al. [14] and Klodas et al. [15]
using PET would divide the group with “significant
ST depression” and negative SPECT findings into
two subgroups: with and without perfusion abnorma-
lities. The former would mostly include patients with
multivessel coronary disease while the latter would
include women with false positive “ischemic ST
changes”. The prognosis in the former group would
be poor but much better in the latter.
The prognostic value of “ischemic ST changes”
as seen during stress tests depends on the proba-
bility that these changes reflect prognostically
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adverse significant coronary stenoses. The impor-
tance of “ischemic ST changes” in case of normal
stress SPECT imaging is related to the balance
between the pretest likelihood of coronary artery
disease and the probability of a false positive result
in a given population. In a population with a low
likelihood of multivessel coronary artery disease
and a high probability of a false positive “ischemic
ST depression”, the latter should be considered
spurious and prognostically insignificant, while the
true prognosis is indicated by true negative SPECT
findings. In contrast, in a population with a low pro-
bability of a false positive “ischemic ST depression”
but high likelihood of multivessel coronary artery
disease that might result in the occurrence of
“balanced ischemia”, one might reasonably expect
a false negative SPECT finding and a true positive
ECG finding, and the latter may suggest worse pro-
gnosis. The use of PET significantly reduces the
probability of obtaining a false negative result and
thus a negative result of this imaging modality in-
dicates good prognosis regardless of the presence
of “ischemic ST depression” that in such a situation
should be considered a false positive finding.
The prognostic value of each test depends on
the likelihood it accurately reflects real phenome-
na determining prognosis. This is expressed by
sensitivity and specifity, as well as by the rates of
occurrence or no occurrence of a cardiac event. It
should be remembered, however, that according to
the Bayes theorem, the prognostic value of a me-
thod may vary depending on the pretest likelihood
of a given condition in the studied population. The
prognostic value of “ichemic ST depression” during
vasodilator stress testing in patients with normal
SPECT/PET myocardial perfusion imaging may
vary depending not only on the severity of corona-
ry artery involvement, but also on age, gender, the
degree of left ventricular dysfunction, and the se-
verity of electrical instability. This issue deserves
further studies.
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